High virologic response rate at End of Treatment (EOT) following triple therapy of previously untreated HCV Genotype 1 (G1) infection with boceprevir in German real-life

2014 ◽  
Vol 52 (08) ◽  
Author(s):  
P Buggisch ◽  
H Löhr ◽  
G Teuber ◽  
H Steffens ◽  
M Kraus ◽  
...  
Keyword(s):  
Triple Therapy ◽  
Response Rate ◽  
Real Life ◽  
Virologic Response ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
End Of Treatment ◽  
Hcv Genotype 1 ◽  
Virologic Response Rate

P1172 “REAL-LIFE”-EXPERIENCE WITH PROTEASE INHIBITOR-TRIPLE THERAPY IN HCV GENOTYPE 1 (G1) PATIENTS (N = 131): SVR 24 RESULTS

2014 ◽  
Vol 60 (1) ◽  
pp. S475
Author(s):  
C.R. Werner ◽  
C. Franz ◽  
D.P. Egetemeyr ◽  
N.P. Malek ◽  
U.M. Lauer ◽  
...  
Keyword(s):  
Protease Inhibitor ◽  
Triple Therapy ◽  
Life Experience ◽  
Real Life ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Hcv Genotype 1
Sign in / Sign up

Export Citation Format

Share Document